China Traditional Chinese Medicine Holdings Co (CHIZF) Stock Statistics & Valuation Metrics
Total Valuation
China Traditional Chinese Medicine Holdings Co has a market cap or net worth of $751.00M. The enterprise value is $5.96B.
- Market Cap
- $751.00M
- Enterprise Value
- $5.96B
Share Statistics
China Traditional Chinese Medicine Holdings Co has 5,035,802,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 5,035,802,000
- Owned by Insiders
- ―
- Owned by Institutions
- 7.85%
Financial Efficiency
China Traditional Chinese Medicine Holdings Co’s return on equity (ROE) is -0.02 and return on invested capital (ROIC) is -1.00%.
- Return on Equity (ROE)
- -0.02
- Return on Assets (ROA)
- -0.01
- Return on Invested Capital (ROIC)
- -1.00%
- Return on Capital Employed (ROCE)
- -0.01
- Revenue Per Employee
- 993.18K
- Profits Per Employee
- -23.04K
- Employee Count
- 14,846
- Asset Turnover
- 0.46
- Inventory Turnover
- 2.06
Valuation Ratios
The current PE Ratio of China Traditional Chinese Medicine Holdings Co is -4.80. China Traditional Chinese Medicine Holdings Co’s PEG ratio is 0.03.
- PE Ratio
- -4.80
- PS Ratio
- 0.39
- PB Ratio
- 0.25
- Price to FCF
- 3.45
- Price to Operating Cash Flow
- 2.92
- PEG Ratio
- 0.03
Income Statement
In the last 12 months, China Traditional Chinese Medicine Holdings Co had revenue of 14.74B and earned -342.07M in profits. Earnings per share was -0.07.
- Revenue
- 14.74B
- Gross Profit
- 7.09B
- Operating Income
- -268.90M
- Pretax Income
- -368.23M
- Net Income
- -342.07M
- EBITDA
- 1.61B
- Earnings Per Share (EPS)
- -0.07
Cash Flow
In the last 12 months, operating cash flow was 1.71B and capital expenditures -261.50M, giving a free cash flow of 1.45B billion.
- Operating Cash Flow
- 1.71B
- Free Cash Flow
- 1.45B
- Free Cash Flow per Share
- 0.29
Dividends & Yields
China Traditional Chinese Medicine Holdings Co pays an annual dividend of $0.01, resulting in a dividend yield of 0.28%
- Dividend Per Share
- $0.01
- Dividend Yield
- 0.28%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 28.99%
- Earnings Yield
- -20.04%
Stock Price Statistics
- Beta
- 0.33
- 52-Week Price Change
- -40.29%
- 50-Day Moving Average
- 0.16
- 200-Day Moving Average
- 0.21
- Relative Strength Index (RSI)
- 0.00
- Average Volume (3m)
- ―
Important Dates
China Traditional Chinese Medicine Holdings Co upcoming earnings date is Mar 19, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 28, 2026
- Next Earnings Date
- Mar 19, 2027
- Ex-Dividend Date
- Jul 07, 2025
Financial Position
China Traditional Chinese Medicine Holdings Co as a current ratio of 2.29, with Debt / Equity ratio of 12.18%
- Current Ratio
- 2.29
- Quick Ratio
- 1.81
- Debt to Market Cap
- 0.26
- Net Debt to EBITDA
- -0.96
- Interest Coverage Ratio
- -2.60
Taxes
In the past 12 months, China Traditional Chinese Medicine Holdings Co has paid 89.86M in taxes.
- Income Tax
- 89.86M
- Effective Tax Rate
- -0.24
Enterprise Valuation
China Traditional Chinese Medicine Holdings Co EV to EBITDA ratio is 2.21, with an EV/FCF ratio of 1.84.
- EV to Sales
- 0.21
- EV to EBITDA
- 2.21
- EV to Free Cash Flow
- 1.84
- EV to Operating Cash Flow
- 1.56
Balance Sheet
China Traditional Chinese Medicine Holdings Co has $4.56B in cash and marketable securities with $1.34B in debt, giving a net cash position of $3.22B billion.
- Cash & Marketable Securities
- $4.56B
- Total Debt
- $1.34B
- Net Cash
- $3.22B
- Net Cash Per Share
- $0.64
- Tangible Book Value Per Share
- $3.18
Margins
Gross margin is 47.46%, with operating margin of -3.27%, and net profit margin of -7.91%.
- Gross Margin
- 47.46%
- Operating Margin
- -3.27%
- Pretax Margin
- -8.18%
- Net Profit Margin
- -7.91%
- EBITDA Margin
- 9.55%
- EBIT Margin
- 0.64%
Analyst Forecast
The average price target for China Traditional Chinese Medicine Holdings Co is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -16.02%
- EPS Growth Forecast
- -297.26%
